Each year, more than 10 million individuals seek emergency care, citing chest pain as their concern. However, only one-fifth of these cases are attributed to heart attacks.
The current approach involves subjecting patients to a series of cardiac tests, leading to prolonged hospitalization for those with non-cardiac causes. Unfortunately, this process hinders care for those truly experiencing a heart attack.
Imagine if there was a technology capable of monitoring the heart’s underlying state in real-time.
Could such innovation significantly improve clinical workflows, enhance the patient experience, and, most crucially, positively impact patient outcomes?
Carlsbad, California (March 19, 2023) – RCE Technologies, Inc.
March 14, 2023 | RCE.ai Significant developments and evolution of medical device technology have occurred in many fields of medicine. One such area was radiology, and studying history helps us understand how the past shaped the medical industry’s trajectory from conception to impact in patient care. Back in 1895, German physics professor Wilhelm Röntgen discovered…
New Orleans, LA (March 6, 2023) – RCE Technologies, Inc’s groundbreaking study titled “A Novel Breakthrough In Wrist-Worn Transdermal Troponin-I-Sensor Assessment For Acute Myocardial Infarction” was presented at the American College of Cardiology – Late Breaking Clinical Trials on March 6, 2023. The presentation was delivered center stage by Dr. Partho Sengupta, Henry Rutgers Professor of…
Carlsbad, California (March 2, 2023) – RCE Technologies, Inc. has just announced a major addition to the clinical team: the highly acclaimed Ronald P. Karlsberg, MD, FACC. As a Clinical Professor of Medicine at the prestigious Smidt Heart Institute at Cedars-Sinai and the David Geffen School of Medicine at UCLA, Dr. Karlsberg has established himself as a leader…
Carlsbad, California (January 16, 2023) – RCE Technologies, Inc. a medical technology company harnessing the power of sensors, machine learning and proprietary algorithms towards heart attack diagnostics, announced today it has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the National Science Foundation (NSF) for $255,892. “It’s an absolute honor to receive this grant from…
Carlsbad, California (December 20, 2022) – RCE Technologies, Inc. has been accepted to present at the American College of Cardiology – Late Breaking Clinical Trials. The presentation titled, “A Novel Breakthrough In Wrist-Worn Transdermal Troponin-I-Sensor Assessment For Acute Myocardial Infarction” will be delivered center stage on March 6, in New Orleans, Louisiana, by Dr. Partho Sengupta, Henry Rutgers…
RCE had the honor to present a poster in “The Intersection of Biomarkers and Health Technology ” session series at the American Heart Association’s 2022 conference in Chicago this November. These are preliminary insights towards the development of the transdermal Troponin sensor. The abstract is published in Circulation. 2022;146:A12766
September 14, 2022 | New Brunswick, NJ With rapid transformation of cardiovascular medicine from reactive to preventive, the Rutgers Robert Wood Johnson University Hospital is investing in the vision of a technology-enabled cardiovascular service that will enhance all aspects of the patient journey by leveraging advanced technologies such as innovative devices, robotics and artificial intelligence…
The clinical team at University of Texas Southwestern (UTSW) presented insights from a pilot study done back in 2021 work, that compared RCE’s wearable sensor with blood based measurements in patients recruited from the Emergency Department, at the Association for Clinical and Translational Science (ACTS) conference. https://www.cambridge.org/core/journals/journal-of-clinical-and-translational-science/article/328-rapid-screening-tool-for-identifying-acute-myocardial-injury-an-exploratory-study-evaluating-the-ability-of-a-novel-noninvasive-device-to-detect-cardiac-troponin/BD829D200B2C0151B6ECCA02504DBEAE This work, now published in the journal of clinical and…
July 18, 2022 | Ventura, CA RCE in collaboration with Texas Heart Institute’s research team, is thrilled with the opportunity to have presented the poster titled: “A Novel Telemedicine Platform for Real-Time Cardiac Injury Biomarker Monitoring.” at the Graft preservation in Heart Transplant at the Gordon Research Conference: The preclinical studies involved understanding the trend of…
May 13, 2022 | Mike Kim Testing is usually perceived as the activity performed AFTER development is complete. If you’re familiar with the medical device industry, you probably heard about Verification & Validation testing: “was the product built right?” or “was the right product was built?” While Verification and Validation is incredibly important, I do…